Sanofi Sponsored ADR Forecast, price target & analysts
Sanofi Sponsored ADR Target price 2025 - Analyst rating & recommendation
Sanofi Sponsored ADR Classifications & Recommendation:
Sanofi Sponsored ADR Price Target
| Target Price | $60.83 |
| Price | $54.14 |
| Potential |
12.37%
register free of charge
|
| Number of Estimates | 21 |
|
21 Analysts have issued a price target Sanofi Sponsored ADR 2026 .
The average Sanofi Sponsored ADR target price is $60.83.
This is
12.37%
register free of charge
$65.67
21.29%
register free of charge
$52.28
3.44%
register free of charge
|
|
| A rating was issued by 24 analysts: 19 Analysts recommend Sanofi Sponsored ADR to buy, 4 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Sanofi Sponsored ADR stock has an average upside potential 2026 of
12.37%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 44.44 | 49.04 |
| 8.69% | 10.36% | |
| EBITDA Margin | 31.98% | 30.74% |
| 1.42% | 3.86% | |
| Net Margin | 13.54% | 18.01% |
| 5.23% | 33.00% |
18 Analysts have issued a sales forecast Sanofi Sponsored ADR 2025 . The average Sanofi Sponsored ADR sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an Sanofi Sponsored ADR EBITDA forecast 2025. The average Sanofi Sponsored ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Sanofi Sponsored ADR Analysts have issued a net profit forecast 2025. The average Sanofi Sponsored ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 2.40 | 3.52 |
| 3.00% | 46.67% | |
| P/E | 15.37 | |
| EV/Sales | 2.99 |
9 Analysts have issued a Sanofi Sponsored ADR forecast for earnings per share. The average Sanofi Sponsored ADR <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Sanofi Sponsored ADR stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Sanofi Sponsored ADR...
Current Sanofi Sponsored ADR Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG | Locked ➜ Locked | Locked | Jan 06 2025 |
| BNP PARIBAS EXANE | Locked ➜ Locked | Locked | Jan 05 2025 |
| BANCO SANTANDER | Locked ➜ Locked | Locked | Dec 17 2024 |
| ODDO BHF | Locked ➜ Locked | Locked | Dec 17 2024 |
| TD COWEN | Locked ➜ Locked | Locked | Dec 17 2024 |
| LEERINK PARTNERS | Locked ➜ Locked | Locked | Dec 16 2024 |
| STIFEL EUROPE | Locked ➜ Locked | Locked | Nov 25 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
BERENBERG: Locked ➜ Locked
|
Jan 06 2025 |
|
Locked
BNP PARIBAS EXANE: Locked ➜ Locked
|
Jan 05 2025 |
|
Locked
BANCO SANTANDER: Locked ➜ Locked
|
Dec 17 2024 |
|
Locked
ODDO BHF: Locked ➜ Locked
|
Dec 17 2024 |
|
Locked
TD COWEN: Locked ➜ Locked
|
Dec 17 2024 |
|
Locked
LEERINK PARTNERS: Locked ➜ Locked
|
Dec 16 2024 |
|
Locked
STIFEL EUROPE: Locked ➜ Locked
|
Nov 25 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
